Drug repositioning for cancer in the era of AI, big omics, and real-world data
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference89 articles.
1. The poor design of clinical trials of statins in oncology may explain their failure – lessons for drug repurposing;Abdullah;Cancer Treat. Rev.,2018
2. Data science, learning, and applications to biomedical and health sciences;Adam;Ann. N.Y. Acad. Sci.,2017
3. DDREL: from drug-drug relationships to drug repurposing;Allahgholi;Intell. Data Anal.,2022
4. Synergistic drug combinations and machine learning for drug repurposing in chordoma;Anderson;Sci. Rep.,2020
5. Old wine in new bottles: drug repurposing in oncology;Antoszczak;Eur. J. Pharmacol.,2020
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes;International Journal of Pharmaceutics;2024-05
2. Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing;Cancers;2024-04-11
3. PDE5 inhibitors against cancer via mediating immune cells in tumor microenvironment: AI‐based approach for future drug repurposing exploration;Interdisciplinary Medicine;2024-03-16
4. Artificial Intelligence for Precision Oncology of Triple-Negative Breast Cancer: Learning from Melanoma;Cancers;2024-02-06
5. A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation;Cancer Letters;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3